Oyster Point Pharma Inc (OYST) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oyster Point Pharma Inc   (NASDAQ: OYST)


Oyster Point Pharma Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Oyster Point Pharma Inc 's ROA in the third quarter of 2022?
Oyster Point Pharma Inc recorded a cumulative net loss of $-235 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -144.86%.

However, within the Healthcare sector 1067 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2022 from to 5434.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change -44.09 % -11.38 % -4.86 % 11.99 % -9.92 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -235 -198 -149 -101 -39
Return On Assets (TTM) -144.86 % -107.94 % -78.81 % -52.78 % -20.85 %
OYST's Total Ranking # 5434 # # # #
Total Assets (TTM) in million 109 143 176 222 195
Seq. Total Assets Change -23.82 % -18.59 % -20.68 % 13.65 % 20.75 %
Seq. Net Income Change - - - - -

OYST's 5 Years Annual ROA >> Back to OYST Management Effectiveness >> Compare OYST ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 165
Sector # 1068
Overall # 5318

Return On Assets Statistics
High Average Low
120.24 %
-13.24 %
-144.21 %
(Mar 31 2020)   (Sep 30 2022)





Financial Statements
Oyster Point Pharma Inc 's Assets $ 109 million OYST's Balance sheet
Oyster Point Pharma Inc 's Income $ -37 million Quarterly OYST's Income Statement
OYST's Income by Division See OYST's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
FY
FY
Y / Y Total Assets Change 11.99 % 38.2 % - - -
Total Assets in million 222 198 143 0 0
Y / Y Net Income Change - - - - -
Net Income in million -101 -71 -46 0 0
Annual Return On Assets -45.42 % -35.63 % -31.92 % - -

OYST's 5 Years Annual ROA >> Back to OYST Management Effectiveness >> Compare OYST ROA to its Competitors



More Return On Assets Ratios
OYST's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OYST's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OYST's Competitors
Subscribers only: Roa for Oyster Point Pharma Inc 's Suppliers
Subscribers only: Return On Assets for OYST's Customers

You may also want to know
OYST's Roi OYST's Inventory Turnover Ratio OYST's Growth Rates OYST's Dividend Comparisons
OYST's Profitability Ratios OYST's Asset Turnover Ratio OYST's Dividend Growth
OYST's Roe OYST's Valuation Ratios OYST's Financial Strength Ratios OYST's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-08-29T17:41:26+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.